Inventor

CHORVAT ROBERT J

US54 patents

⚠️ This page may combine multiple inventors who share the name “CHORVAT ROBERT J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHORVAT ROBERT J

SEARLE & CO

Phenylpiperazine phosphonates

25-Halocholest-5-ene-3β,22-diols and esters thereof

Azanaphthaleneacetic acid derivatives

Octahydropyrido[1,2-c]pyrimidinones and hexahydropyrido[1,2-c]pyrimidinediones

Substituted 5-phenyl-5-(aminoalkyl)-1,3-diazabicyclo[4.4.0]decan-4-ones and 5-phenyl-5-(aminoalkyl)-1,3-diazabicyclo[4.4.0]dec-2-en-4-ones

24-Cyclopropylcholene-3β, 22-diols and esters thereof

25-Alkylcholest-5-ene-3 β,22-diols and esters thereof

2,3-Dihydro-3-oxo-5H-pyrido[3,4-b][1,4]-benzothiazine-4-carbonitriles

Monobasic disobutamide derivatives

Monobasic disobutamide derivatives

4H-1,4-Benzothiazine derivatives

Hexahydroindolizinones useful for treating cardiac arrhythmia, thrombotic disorders in mammals

2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents

25-Substituted-5α-cholestane-3β,22S-diol

7-aza-6-alkoxy-1-tetralones

11β-Alkyl-2-azaestratrienes and intermediates

Process and intermediates for manufacture of 2-azasterioids

Process for antiarrhythmic 1,3-diazabicyclo[4.4.0]dec-2-en-4-ones

4H-1,4-Benzothiazine derivatives and intermediates thereto

MCELROY JOHN F

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Purine compounds as cannabinoid receptor blockers

Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

JENRIN DISCOVERY INC

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

MAO-B inhibitors useful for treating obesity

JENRIN DISCOVERY

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

SEARLE G D &

25-Alkyl-3β-hydroxycholest-5-en-7-ones and esters thereof

3,9-Dihydro-3,9-dioxo-2H-indeno(2,1-c)-pyridine-4-(carbonitriles/carboxamides)

25-Alkylcholest-5-ene-3β,22-diols and esters thereof

MCELROY JOHN FRANCIS

Substituted picolinamides as MAO-B inhibitors useful for treating obesity

MAO-B inhibitors useful for treating obesity

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

ACAD PHARMACEUTICALS INCORPORATED

Ultra short acting anti-arrhythmic agents

Ultra short acting anti-arrhythmic agents

ACAD PHARMACEUTICALS INC

Ultra short acting anti-arrhythmic agents

Ultra short acting anti-arrhythmic agents

JENRIN DISCOVERY LLC

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

G D SERLE & CO

Benzothiazine derivatives

JENRM DISCOVERY INC

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes